RxDoctor Payments Data

Samer Salmo, MD

Psychiatry · San Jose, CANPI 1326277567

Payments from drug & device makers

$1,154in general payments, 2019–2025

Across 63 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$341
  • Sunovion Pharmaceuticals Inc.$224
  • Takeda Pharmaceuticals U.S.A., Inc.$161
  • Lundbeck LLC$144
  • Otsuka America Pharmaceutical, Inc.$96
  • Shire North American Group Inc$62
  • plus $126 from 3 others

What the payments were for

  • Food & beverage$1,08694%
  • Education$696%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,154 in reported general payments places this provider in the 75th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$18,448
Medicare patients
21
Services billed
155

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Chlorpromazine Hcl16$5,008
VyvanseLisdexamfetamine Dimesylate12$4,473
Trazodone Hcl152$3,062
Bupropion XlBupropion Hcl101$2,470
Divalproex Sodium ErDivalproex Sodium64$2,154
Aripiprazole52$2,078
Lurasidone Hcl15$2,029
Duloxetine Hcl79$1,403
Quetiapine Fumarate104$1,212
Gabapentin68$1,030
Olanzapine35$902
Venlafaxine Hcl ErVenlafaxine Hcl67$851
Escitalopram Oxalate51$811
Lamotrigine56$608
Fluoxetine Hcl38$546

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$161$4,47312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,954 psychiatry providers in California.

Other psychiatry in San Jose

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →